World Health Organization

The primary purposes of this framework are to: 1) promote, enhance, and intensify TB research and innovation at the country level, and 2) promote, enhance, and catalyze TB research at the global level through advocacy, innovation, discussion of global priorities, and the development of networks for research and capacity building.

This document shares best practices in engagement of health care providers in programmatic management of drug-resistant tuberculosis that have been documented in different countries and regions and implemented by different stakeholders. Case studies presented in the document are lessons learned for scale-up of public-private mix for the management of drug-resistant TB at country level.

This fact sheet provides information on the connection between TB and diabetes and outlines activities where TB and diabetes programs can collaborate.

This document highlights how the Ministries of Health of the 30 highest TB burden countries, and their partners, are beginning to adopt, adapt and implement the End TB Strategy.

This training course uses a variety of methods of instruction to help health workers develop specific skills necessary to diagnose persons with TB and manage treatment for their patients.

This report sets out the rationale for the ProTest Initiative (Promotion of Voluntary Testing), based on an analysis of the impact of HIV on TB control. It describes the elements of the ProTest approach, reviews progress so far, and sets out the future direction. The purpose of the report is to generate discussion and ideas that will help the Initiative establish a comprehensive range of interventions needed to control TB in settings with high prevalence of HIV infection.

This booklet explains the relationship between MDR-TB, DOTS, and DOTS-Plus and how projects can become a DOTS-Plus pilot project that can benefit from concessionary prices negotiated for second-line anti-TB drugs by the Working Group.

This book was developed to assist in the management of TB and HIV/AIDS programs that are implementing or planning to implement collaborative TB/HIV activities. It is intended to facilitate the collection of standardized data and help in the interpretation and dissemination of these data for program improvement. It aims to ensure consistency across all agencies and stakeholders involved in HIV/AIDS, TB, and collaborative TB/HIV activities.

This compendium report provides a detailed review of monitoring and evaluation (M&E) for national TB programs and indicators for measuring DOTS implementation and expansion. The review includes information on M&E for TB control programs, sources of data, and effective use of M&E data for program improvement and advocacy.

This is the seventeenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 204 countries and territories that account for over 99% of the world’s TB cases.